0	8	Specific	specific	JJ
9	17	NF-kappa	NF-kappa	NNP
18	19	B	B	NNP
20	28	subunits	subunit	NNS
29	32	act	act	VBP
33	35	in	in	IN
36	43	concert	concert	NN
44	48	with	with	IN
49	52	Tat	Tat	NNP
53	55	to	to	TO
56	65	stimulate	stimulate	VB
66	71	human	human	JJ
72	88	immunodeficiency	immunodeficiency	NN
89	94	virus	virus	NN
95	99	type	type	NN
100	101	1	1	CD
102	115	transcription	transcription	NN
115	116	.	.	.

118	126	NF-kappa	NF-kappa	NNP
127	128	B	B	NNP
129	131	is	be	VBZ
132	133	a	a	DT
134	141	protein	protein	NN
142	149	complex	complex	NN
150	155	which	which	WDT
156	165	functions	function	VBZ
166	168	in	in	IN
169	176	concert	concert	NN
177	181	with	with	IN
182	185	the	the	DT
186	191	tat-I	tat-i	NN
192	196	gene	gene	NN
197	204	product	product	NN
205	207	to	to	TO
208	217	stimulate	stimulate	VB
218	223	human	human	JJ
224	240	immunodeficiency	immunodeficiency	NN
241	246	virus	virus	NN
247	248	(	(	(
248	251	HIV	HIV	NNP
251	252	)	)	)
253	266	transcription	transcription	NN
266	267	.	.	.

268	270	To	to	TO
271	280	determine	determine	VB
281	288	whether	whether	IN
289	297	specific	specific	JJ
298	305	members	member	NNS
306	308	of	of	IN
309	312	the	the	DT
313	321	NF-kappa	NF-kappa	NNP
322	323	B	B	NNP
324	330	family	family	NN
331	341	contribute	contribute	VBP
342	344	to	to	TO
345	349	this	this	DT
350	356	effect	effect	NN
356	357	,	,	,
358	360	we	we	PRP
361	365	have	have	VBP
366	374	examined	examine	VBN
375	378	the	the	DT
379	388	abilities	ability	NNS
389	391	of	of	IN
392	401	different	different	JJ
402	410	NF-kappa	NF-kappa	NNP
411	412	B	B	NNP
413	421	subunits	subunit	NNS
422	424	to	to	TO
425	428	act	act	VB
429	433	with	with	IN
434	439	Tat-I	Tat-I	NNP
440	442	to	to	TO
443	452	stimulate	stimulate	VB
453	466	transcription	transcription	NN
467	469	of	of	IN
470	473	HIV	HIV	NNP
474	476	in	in	IN
477	483	Jurkat	Jurkat	NNP
484	494	T-leukemia	T-leukemia	NNP
495	500	cells	cell	NNS
500	501	.	.	.

502	504	We	we	PRP
505	509	have	have	VBP
510	515	found	find	VBN
516	520	that	that	IN
521	524	the	the	DT
525	533	p49(100)	p49(100)	NN
534	537	DNA	dna	NN
538	545	binding	binding	NN
546	553	subunit	subunit	NN
553	554	,	,	,
555	563	together	together	RB
564	568	with	with	IN
569	572	p65	p65	NN
572	573	,	,	,
574	577	can	can	MD
578	581	act	act	VB
582	584	in	in	IN
585	592	concert	concert	NN
593	597	with	with	IN
598	603	Tat-I	Tat-I	NNP
604	606	to	to	TO
607	616	stimulate	stimulate	VB
617	620	the	the	DT
621	631	expression	expression	NN
632	634	of	of	IN
635	642	HIV-CAT	HIV-CAT	NNP
643	650	plasmid	plasmid	NN
650	651	.	.	.

652	658	Little	little	JJ
659	665	effect	effect	NN
666	669	was	be	VBD
670	678	observed	observe	VBN
679	683	with	with	IN
684	690	50-kDa	50-kda	JJ
691	696	forms	form	NNS
697	699	of	of	IN
700	704	p105	p105	NN
705	713	NF-kappa	NF-kappa	NNP
714	715	B	B	NNP
716	718	or	or	CC
719	722	rel	rel	NN
722	723	,	,	,
724	726	in	in	IN
727	738	combination	combination	NN
739	743	with	with	IN
744	747	p65	p65	NN
748	750	or	or	CC
751	762	full-length	full-length	JJ
763	768	c-rel	c-rel	NN
768	769	,	,	,
770	775	which	which	WDT
776	778	do	do	VBP
779	782	not	not	RB
783	792	stimulate	stimulate	VB
793	796	the	the	DT
797	800	HIV	HIV	NNP
801	809	enhancer	enhancer	NN
810	812	in	in	IN
813	818	these	these	DT
819	824	cells	cell	NNS
824	825	.	.	.

826	831	These	these	DT
832	840	findings	finding	NNS
841	848	suggest	suggest	VBP
849	853	that	that	IN
854	857	the	the	DT
858	869	combination	combination	NN
870	872	of	of	IN
873	881	p49(100)	p49(100)	NN
882	885	and	and	CC
886	889	p65	p65	NN
890	898	NF-kappa	NF-kappa	NNP
899	900	B	B	NNP
901	904	can	can	MD
905	908	act	act	VB
909	911	in	in	IN
912	919	concert	concert	NN
920	924	with	with	IN
925	928	the	the	DT
929	934	tat-I	tat-i	NN
935	939	gene	gene	NN
940	947	product	product	NN
948	950	to	to	TO
951	960	stimulate	stimulate	VB
961	964	the	the	DT
965	974	synthesis	synthesis	NN
975	977	of	of	IN
978	981	HIV	HIV	NNP
982	985	RNA	RNA	NNP
985	986	.	.	.